Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1Breast 1

Conditions

Urogenital Neoplasms 1Sarcoma 1Gastrointestinal Neoplasms 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 3Sunitinib 3Radiosurgery 2Observation 2IDRX-42 2trastuzumab deruxtecan 1repotrectinib 1ponatinib 1pazopanib 1nilotinib 1montanide ISA 51 1atezolizumab 1amminedichloro(2-methylpyridine)platinum(II) 1alectinib 1Transurethral Resection of Prostate 1Sildenafil Citrate 1Radiotherapy 1Quality of Life 1Poly(ADP-ribose) Polymerase Inhibitors 1Oncolytic Virotherapy 1Microscopy, Electron 1Interleukin-2 1Injections 1Imatinib Mesylate 1Drug Therapy 1Doxorubicin 1Cytoreduction Surgical Procedures 1Cryosurgery 1Cisplatin 1CYT-6091 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Sildenafil Citrate × Sarcoma × Clear all
NCT01375699 2019-08-26

Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers

Virginia Commonwealth University

Phase 1 Completed
26 enrolled
BreastGastrointestinalSarcoma

Breast Neoplasms, Gastrointestinal Neoplasms, Sarcoma, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡